Search for: "PFIZER V APOTEX"
Results 1 - 20
of 211
Sort by Relevance
|
Sort by Date
19 Mar 2024, 8:54 am
See Pfizer, Inc. v. [read post]
5 Mar 2024, 10:23 am
Pfizer v. [read post]
24 Mar 2021, 2:32 pm
” Pfizer, Inc. v. [read post]
17 Mar 2020, 1:32 pm
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
3 Mar 2020, 4:00 am
Bell Helicopter Textron Canada Limitée, 2012 FC 113 citing Pfizer Canada Inc v Apotex Inc, 2007 FC 971, the Court said it is entitled to look at all the patents and other publications that a skilled technician would discover in a ‘reasonable and diligent search’ to determine whether the resulting ‘mosaic’ leads directly to the invention. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 48. [12] See Free World Trust, supra, at paragraph 13; Apotex Inc v Wellcome Foundation Ltd, 2002 SCC 77 at paragraph 37, [2002] 4 SCR 153; AstraZeneca Canada Inc v Apotex Inc, 2017 SCC 36 at paragraph 39, [2017] 1 SCR 943 [13] See Free World Trust, supra, at paragraphs 33–43; applied in Seedlings Life Science Ventures, LLC v. [read post]
14 May 2019, 11:24 am
Cir. 2009) (quoting Pfizer, Inc. v. [read post]
13 May 2019, 9:21 am
Cir. 2009) (quoting Pfizer, Inc. v. [read post]
28 Jul 2018, 4:07 pm
[Footnote omit-ted.]Within Pfizer v. [read post]
13 Jul 2018, 5:48 pm
See Pfizer, Inc. v. [read post]
24 May 2018, 12:27 am
’” Pfizer, Inc. v. [read post]
14 Jan 2018, 1:37 pm
”Pfizer, Inc. v. [read post]
9 Nov 2017, 9:00 pm
Pfizer, Inc. v. [read post]
25 Aug 2017, 6:54 pm
” Pfizer, Inc. v. [read post]
2 Jul 2017, 12:52 am
O Canada, thank you for getting rid of thePromise Doctrine The Court's Analysis The utility requirement is a necessary pre-condition to patentability - if the invention that a patent purports to protect is not useful, it cannot be an invention (Apotex v Wellcome (2002 SCC 77), Teva v Pfizer). [read post]
1 Jul 2017, 9:39 am
O Canada, thank you for getting rid of thePromise Doctrine The Court's Analysis The utility requirement is a necessary pre-condition to patentability - if the invention that a patent purports to protect is not useful, it cannot be an invention (Apotex v Wellcome (2002 SCC 77), Teva v Pfizer). [read post]
18 Nov 2016, 12:44 am
John Collins, Sumer Dayal and Natalie ShoolmanClayton Utz by John Collins, Natalie Shoolman & Sumer Dayal On 21 October 2016, the Federal Court of Australia handed down its judgment in the case of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) [2016] FCA 1238 (FCA Judgment). [read post]
21 Jun 2016, 4:00 am
Absent more definitive consistent instruction from the Federal Court of Appeal, or direct SCC pronouncement on the proper approach, patent drafters are still advised to keep their promises to a minimum to avoid disclosure challenges regarding sound prediction. _________________________ [1] Eli Lilly v Hospira 2016 FC 47 (Barnes) [2] Gilead v Idenix 2015 FC 1156 at para 381 (Annis), under appeal A-483-15, adopting earlier reasoning of Astra v Apotex 2014 FC 638… [read post]
24 Mar 2016, 4:00 am
The Federal Court recently held, in Apotex Inc. v. [read post]
22 Mar 2016, 4:00 am
Vertical consolidation and focus on niche therapeutic areas are also growth areas for manufacturers. ___________________________ [1] As listed in the FDA’s biologic listings – Purple Book (http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm411418.htm) [2] Amgen v Apotex 2015 FC 1261 (Hughes J) at paras. 101, 106 [3] Partners signed the TPP on February 5, 2016. [read post]
